Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5568
Source ID: NCT00240370
Associated Drug: Muraglitazar
Title: A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes
Interventions: DRUG: Muraglitazar
Outcome Measures: Primary: Compare change from basline in HbA1c after 24 weeks and 50 weeks of treatment with muraglitazar + metformin vs. pioglitazone + metformin | Secondary: Change in FPG from basline to W24, proportion of subjects receiving therapeutic response at W24, percent change of fasting lipid levels from baseline to W11/12, change in|hs-CRP from baseline to W24
Sponsor/Collaborators: Sponsor: Bristol-Myers Squibb
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 1159
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Start Date: 2003-10
Completion Date:
Results First Posted:
Last Update Posted: 2010-09-14
Locations: Local Institution, Birmingham, Alabama, United States|Local Institution, Columbiana, Alabama, United States|Local Institution, Mesa, Arizona, United States|Local Institution, Peoria, Arizona, United States|Local Institution, Carlisle, Arkansas, United States|Local Institution, Jonesboro, Arkansas, United States|Local Institution, Little Rock, Arkansas, United States|Local Institution, Pine Bluff, Arkansas, United States|Local Institution, Sherwood, Arkansas, United States|Local Institution, Anaheim, California, United States|Local Institution, Artesia, California, United States|Local Institution, Encino, California, United States|Local Institution, Encintas, California, United States|Local Institution, Fresno, California, United States|Local Institution, Long Beach, California, United States|Local Institution, Los Angeles, California, United States|Local Institution, Northridge, California, United States|Local Institution, Denver, Colorado, United States|Local Institution, Hamden, Connecticut, United States|Local Institution, Altamonte Springs, Florida, United States|Local Institution, Hollywood, Florida, United States|Local Institution, Jacksonville, Florida, United States|Local Institution, Miami, Florida, United States|Local Institution, New Port Richie, Florida, United States|Local Institution, St. Cloud, Florida, United States|Local Institution, W Palm Beach, Florida, United States|Local Institution, Honolulu, Hawaii, United States|Local Institution, Evansville, Indiana, United States|Local Institution, Lafayette, Indiana, United States|Local Institution, New Orleans, Louisiana, United States|Local Institution, Shreveport, Louisiana, United States|Local Institution, Baltimore, Maryland, United States|Local Institution, Detroit, Michigan, United States|Local Institution, Gulfport, Mississippi, United States|Local Institution, St. Louis, Missouri, United States|Local Institution, Omaha, Nebraska, United States|Local Institution, Endwell, New York, United States|Local Institution, Cary, North Carolina, United States|Local Institution, Charlotte, North Carolina, United States|Local Institution, Morehead, North Carolina, United States|Local Institution, Raleigh, North Carolina, United States|Local Institution, Statesville, North Carolina, United States|Local Institution, Wilmington, North Carolina, United States|Local Institution, Winston-Salem, North Carolina, United States|Local Institution, Bellbrook, Ohio, United States|Local Institution, Maumee, Ohio, United States|Local Institution, Thornville, Ohio, United States|Local Institution, Oklahoma City, Oklahoma, United States|Local Institution, Portland, Oregon, United States|Local Institution, Camp Hill, Pennsylvania, United States|Local Institution, Melrose Park, Pennsylvania, United States|Local Institution, Pittsburgh, Pennsylvania, United States|Local Institution, West Chester, Pennsylvania, United States|Local Institution, Youngwood, Pennsylvania, United States|Local Institution, East Providence, Rhode Island, United States|Local Institution, Charleston, South Carolina, United States|Local Institution, Clinton, South Carolina, United States|Local Institution, Memphis, Tennessee, United States|Local Institution, Austin, Texas, United States|Local Institution, Carrollton, Texas, United States|Local Institution, Corpus Christi, Texas, United States|Local Institution, Dallas, Texas, United States|Local Institution, Houston, Texas, United States|Local Institution, Midland, Texas, United States|Local Institution, San Antonio, Texas, United States|Local Institution, Salt Lake City, Utah, United States|Local Institution, Lebanon, Virginia, United States|Local Institution, Spokane, Washington, United States|Local Institution, Tacoma, Washington, United States|Local Institution, Bluefield, West Virginia, United States|Local Institution, Red Deer, Alberta, Canada|Local Institution, Vancouver, British Columbia, Canada|Local Institution, Sarnia, Ontario, Canada|Local Institution, Bonaventure, Quebec, Canada|Local Institution, Drummondville, Quebec, Canada|Local Institution, Montreal, Quebec, Canada|Local Institution, Rimouski, Quebec, Canada|Local Institution, Tijuana, Baja California, Mexico|Local Institution, Mexico City, Distrito Federal, Mexico|Local Institution, Mexico, Durango, Mexico|Local Institution, Cuernavaca, Morelos, Mexico|Local Institution, Aguascalientes, Mexico|Local Institution, Chihuahua, Mexico|Local Institution, Aguas Buenas, Puerto Rico|Local Institution, Ponce, Puerto Rico
URL: https://clinicaltrials.gov/show/NCT00240370

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress